Ambulatory Infusion Center Market Size, Share, Growth, and Industry Growth by Type (Hospital, Clinic, and Home Health Agencies) By Application (Cancer, Chronic Disease, and Others) Regional Forecast To 2031

Updated On: 08 April 2024

AMBULATORY INFUSION CENTER MARKET REPORT OVERVIEW

• 
• Request Free Sample PDF to learn more about this report

global ambulatory infusion center market size was USD 80400 million in 2022 and market is projected to touch USD 173185.8 Million By 2031, exhibiting a CAGR of 8.9% during the forecast period.

The global COVID-19 pandemic has been unprecedented and staggering, with ambulatory infusion center experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.

Treatment for chronic health problems including cancer, immune deficiencies, chronic inflammatory diseases, hemophilia, congestive heart failure, Crohn's disease, multiple sclerosis, rheumatoid arthritis, malnutrition, and dehydration, among others is the focus of ambulatory infusion centers. Ambulatory infusion may be delivered by neighborhood pharmacies, hospitals, and home health services, to name a few of the organizations. During an ambulatory infusion, a catheter or needle is used to administer a number of fluids and medications into the circulation intravenously.

COVID-19 Impact: Shut Down of Several Academic and Research Institutions Hindered the Market

Because there is a greater danger of spreading the coronavirus when performing infusion operations, the COVID-19 pandemic has had a detrimental impact on the market for ambulatory infusion centers. In order to prevent COVID-19 infections, several academic and research institutions are recommending safety precautions when a variety of medications are administered using infusion techniques. Due to these factors, the ambulatory infusion center market experienced a decline during the COVID-19 pandemic.

LATEST TRENDS

"Rise in Cancer Among the Population to Boost the Market Growth"

Due to the increased incidence of cancer, it is predicted that the global market for ambulatory infusion centers would grow over the forecast period. For example, according to Our World in Data, an organization that focuses on research and data of the biggest health issues facing the world, an estimated 9.6 million people were estimated to have died from various cancers worldwide, and the organization also stated that every sixth death worldwide was caused by cancer. As a result, the rising incidence of cancer will increase demand for cutting-edge therapies and diagnostics, fueling the expansion of the ambulatory infusion center market.  

AMBULATORY INFUSION CENTER MARKET SEGMENTATION

• 
• Request Free Sample PDF to learn more about this report

• By Type Analysis

By type, market is segmented into hospital, clinic and home health agencies. The hospital segment will dominate the market in the coming years.

• By Application Analysis

Based on applications, the market is classified into cancer, chronic disease and others. The cancer segment will lead the global share through 2031.

DRIVING FACTORS

"Rise in Cancer Cases to Push the Market Demand"

The main forces behind the growth of ambulatory infusion centres for the treatment of various diseases, such as cancer, multiple sclerosis, and digestive disorders, are increased incidence rates of these conditions globally. During the anticipated period, it is also anticipated that the introduction of new services by key companies, such as ambulatory infusion centres for chemotherapy, will fuel the growth of the global ambulatory infusion centre market. For instance, Cedar-Sinai debuted the Samuel Oschin Cancer Center in Los Angeles in June 2020. This facility has a 45,000-square-foot outpatient facility that provides ambulatory infusion therapies to cancer patients. These elements will encourage market expansion in the coming years.

"Demand for Advanced Medical Procedures to Fight Chronic Diseases Will Favor Market Growth"

Significant drivers of the growth of the worldwide ambulatory surgical procedures market include the increased surgical burden on traditional surgery facilities, need for rapid surgery, and an increase in the number of surgical operations. Additionally, advantages that ambulatory surgery centres have over traditional hospitals, such as increased safety and quality, cheaper costs of care, and ease of accessibility, are anticipated to increase demand for ambulatory surgical procedures globally throughout the course of the projected period. These factors will drive the ambulatory infusion center market share during the next few years.

RESTRAINING FACTORS

"Adverse Reactions Post Ambulatory Infusion to Slow Down the Market Demand"

Ambulatory infusion causes a number of adverse reactions in patients, including coughing, flushing, nausea, and itching at the infusion site. The patients' fear of experiencing such adverse effects is one of the main causes of the ambulatory infusion clinics' demise. In addition, the global market for ambulatory infusion centers is experiencing growth restrictions due to rising installation costs, a shortage of healthcare workers, and a load on the supply of medical equipment. These factors will hamper the market trends in the forthcoming years.

AMBULATORY INFUSION CENTER MARKET REGIONAL INSIGHTS

• 
• Request Free Sample PDF to learn more about this report

"North America to Grow and Hold the Largest Share in the Market."

Due to prominent players focusing on creating service facilities for ambulatory infusion for the treatment of various diseases such as cancer and others, North America is likely to hold a leading position in the global ambulatory infusion center market during the projected decade. For instance, the USC School of Medicine's Keck Medicine division announced in May 2018 the addition of a new clinic to its network of ambulatory clinics. For patients with a wide range of ailments, including cancer and digestive issues, the new facility offers a broad array of general care and specialized therapies, including ambulatory infusion services.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

List of Market Players Profiled

• Option Care Health (U.S.)
• Coram CVS (U.S.)
• UnitedHealth Group (U.S.)
• HCA Healthcare (U.S.)
• McLaren (UK.)
• UK HealthCare (UK.)
• CHI Health (U.S.)
• Accredo Health (U.S.)
• PharMerica (U.S.)
• Cleveland Clinic (U.S.)

REPORT COVERAGE

The market research study examines the worldwide market in detail, focusing on important elements such as leading players, product/services or type, and leading end-use applications. Aside from that, the research analyses major advancements and provides insights into lighting market trends. In addition to the causes indicated above, the paper includes a number of other factors that have contributed to recent growth.